PRAX
Praxis Precision Medicines IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$9.58B
P/E Ratio
—
EPS
$-13.40
Beta
2.78
52W High
$358.76
52W Low
$35.21
50-Day MA
$322.26
200-Day MA
$223.84
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Praxis Precision Medicines Inc
Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. The company is headquartered in Cambridge, Massachusetts.
Fundamentals
| Revenue (TTM) | $7.46M |
| Gross Profit (TTM) | $-284.30M |
| EBITDA | $-357.20M |
| Operating Margin | 0.00% |
| Return on Equity | -35.30% |
| Return on Assets | -23.00% |
| Revenue/Share (TTM) | $0.35 |
| Book Value | $50.61 |
| Price-to-Book | 6.80 |
| Price-to-Sales (TTM) | 953.14 |
| EV/Revenue | 1215.61 |
| EV/EBITDA | -6.86 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 1349.00% |
| Shares Outstanding | $27.88M |
| Float | $24.01M |
| % Insiders | 0.32% |
| % Institutions | 115.78% |
Historical Volatility
HV 10-Day
52.99%
HV 20-Day
45.23%
HV 30-Day
53.12%
HV 60-Day
58.51%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($652.18 target)
2
Strong Buy13
Buy1
Hold1
SellMore HEALTHCARE Stocks
Data last updated: 5/25/2026